Primary study · included by 1 review

Eptinezumab improved patient-reported outcomes in patients with migraine and medication-overuse headache: Subgroup analysis of the randomized PROMISE-2 trial.

Starling 2023 · Starling Amaal J, Cowan Robert P, Buse Dawn C, et al. · Headache · 2023

Included by

A meta-analysis of pain intensity changes after placebo interventions in facial pain.

Non-Cochrane · other · 2026 · cited as Starling 2023 · Results para 1 included-study citation list (ref 111); 116 refs cited for 115 stated studies; Supplemental Tables 1 and 2 not available

The review does not say which of its outcomes this study informs.

1 including review in total.